The October issue includes studies and articles on therapeutic drug monitoring of biologics in inflammatory bowel disease; genetic risks of psychiatric conditions associated with pancreatitis pain; and updated clinical guidelines from the American College of Gastroenterology on benign anorectal disorder management.
“The advent of new techniques, new therapies and even new disorders that are changing the everyday landscape of daily practice warrant dissemination to the scientific community,” Co-Editors-in-Chief Brian Lacy, MD, PhD, and Brennan Spiegel, MD, said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.